Showing results (341-350 of 422) with videos related to

Sort By:
Pageof 43
Bipolar Disorders|March 17, 2001
Emerging trends in the treatment of rapid cycling bipolar disorder: a selected reviewR M Post, M A Frye, K D Denicoff, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2017
Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan AfricaRuth L Goodall, David T Dunn, Peter Nkurunziza, et al.
HIV Clinical Trials|October 18, 2017
HIV prevention trial design in an era of effective pre-exposure prophylaxisAmy Cutrell, Deborah Donnell, David T Dunn, et al.
AIDS Research and Human Retroviruses|May 9, 2015
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase InhibitorsJonathan K Kayondo, Nicaise Ndembi, Chris M Parry, et al.
Toxicologic Pathology|November 2, 2014
Retinal Toxicity Induced by a Novel β-secretase Inhibitor in the Sprague-Dawley RatMark R Fielden, Jonathan Werner, Jeff A Jamison, et al.
Environmental Health Perspectives|January 27, 2010
Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science SubcommitteeSyril Pettit, Shelley Ann des Etages, Louis Mylecraine, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2020
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJean L Mbisa, Juan Ledesma, Peter Kirwan, et al.
Brain : a Journal of Neurology|July 25, 2000
Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axonsS C Barnett, C L Alexander, Y Iwashita, et al.
Thyroid : Official Journal of the American Thyroid Association|October 19, 1999
Monomorphic teratoma of the ovary: a rare cause of triiodothyronine toxicosisP H Simkin, L A Ramirez, S L Zweizig, et al.
Journal of Clinical Psychopharmacology|May 15, 2009
A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorderS Nassir Ghaemi, William S Gilmer, Robert T Dunn, et al.
Pageof 43